1 completed. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
Follow Multiple Sclerosis, Secondary Progressive: new trials by email Literature Review of Multiple Sclerosis, Secondary Progressive trials Research Report on Multiple Sclerosis, Secondary Progressive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Novel Imaging Markers in SPMS Ferumoxytol infusion, Gadoteridol, MRI Brain and Cervical Spine - Secondary Progressive Multiple Sclerosis, Multiple Sclerosis, Secondary Progressive | Early Phase 1 | Completed | University of Utah | 11 | 2022-06-01 | 2026-08-13 |
Multiple Sclerosis (1) · Multiple Sclerosis, Chronic Progressive (1)
Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Chronic Disease (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Disease Attributes (1) · Immune System Diseases (1) · Nervous System Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Ferrosoferric Oxide (1) · gadoteridol (1)
United States (1)
M. Mateo Paz Soldan, MD, PhD (1)
UL1TR002538 (1)